U.S. Software Stock News

Hims & Hers Health (HIMS) is back in focus after its second quarter 2026 earnings, which showed US$753.2 million in sales alongside a shift from profit to a US$86.3 million net loss. See our latest analysis for Hims & Hers Health. Over the past year, Hims & Hers Health has combined a 26.9% 90 day share price return with a 1 year total shareholder return that declined 36.4%, which suggests recent momentum has improved even as longer term holders still sit on sizeable gains from earlier...

Goldman Sachs Group stock has delivered a very large 228.6% return over the past three years, and at the current price some of the valuation checks suggest it no longer looks obviously cheap even though market multiples still screen as supportive. The 228.6% gain over three years sets a high bar for fresh upside and raises the question of how much of Goldman Sachs Group's recent strength is already reflected in the share price. Strong activity in equity trading, M&A and AI related dealmaking...

Philip Morris International has delivered a strong 129.5% return over the past 5 years, yet the stock now sits in an interesting spot where the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside while the broader valuation checks suggest it is not an obvious bargain. Over 5 years, Philip Morris International has returned 129.5%, which puts recent gains front and center when judging how much value is left in the share price. The expanded US$1.2b investment in ZYN...

Why Madrigal Pharmaceuticals Earnings Are Back in Focus Madrigal Pharmaceuticals (MDGL) recently reported second quarter and six month results that showed higher net losses year over year, prompting fresh attention on the stock’s financial trajectory ahead of its upcoming investor conference. See our latest analysis for Madrigal Pharmaceuticals. Madrigal Pharmaceuticals shares trade at $515.34, with a 7 day share price return of 6.92% and a year to date decline of 13.22%. The 1 year total...

Over the last 7 days, the United States market has risen by 2.2%, contributing to a remarkable 21% increase over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying undervalued stocks can offer potential opportunities for investors looking to capitalize on companies that may be trading below their intrinsic value despite strong market performance.

The United States market has shown robust performance, climbing 2.2% in the last week and rising 21% over the past year, with earnings projected to grow by 17% annually in the coming years. In such a thriving environment, growth companies with high insider ownership can be particularly appealing as they often reflect strong internal confidence and potential for sustained success.

The market has climbed 2.2% in the last 7 days and is up 21% over the past year, with earnings forecast to grow by 17% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still offer surprising value when built on solid financials. In this article, we explore three penny stocks that combine balance sheet strength with potential for outsized gains, offering investors a chance to discover hidden value in quality companies.

The United States market has experienced a notable uptick, rising 2.2% over the last week and 21% over the past year, with earnings projected to grow by 17% annually. In such a promising environment, identifying dividend stocks that offer both steady income and potential for capital appreciation can be an effective strategy for investors looking to bolster their portfolios.

In recent days, Brinker International has drawn attention as analysts highlighted Chili’s continued operational strength, with upbeat expectations ahead of the now‑past August 12 fiscal fourth‑quarter 2026 earnings release. An interesting angle is how management’s focus on guest traffic, value positioning, and restaurant productivity at Chili’s is increasingly central to bullish analyst expectations. We’ll now examine how this optimism around Chili’s operating momentum may reshape Brinker...

In August 2026, PureCycle Technologies reported second-quarter 2026 results showing sales rising to US$4.51 million from US$1.65 million a year earlier, alongside a net loss of US$142.22 million and record PureFive® production of 4.5 million pounds on 5.0 million pounds of feedstock processed. An interesting takeaway is that while six‑month sales nearly tripled to US$8.64 million, the six‑month net loss widened to US$175.66 million as the company continued scaling up operations. With record...

Peloton Interactive (PTON) has just reported its first full year of positive net and operating income while guiding for a decline in fiscal 2027 revenue, creating a mixed backdrop for the stock. See our latest analysis for Peloton Interactive. At a share price of US$5.51, Peloton Interactive has had a mixed run, with the 7-day share price return down 14.57% and the year-to-date share price return down 9.97%, while the 1-year total shareholder return has declined 33.21%. This points to fading...

Parents now have fresh tax rules to work with, and that could quietly reshape where household savings flow next. With Trump Accounts opening the door to pre tax contributions for children, more money may sit in investments for longer. That is why investors are watching which financial services and asset management stocks are closely tied to this trend. This article walks through three such stocks from the screener and how they might be affected. The three stocks below are just a sample, with...

Zai Lab (ZLAB) is back in focus after its second quarter 2026 earnings update, which showed revenue of US$106.31 million and a wider net loss, alongside fresh attention on newly approved products in China. See our latest analysis for Zai Lab. At a share price of US$23.57, Zai Lab has seen strong short term momentum, with a 7 day share price return of 29.65% and year to date share price return of 36.01%. The 1 year total shareholder return is still down 32%, which signals that recent...

Why EPR Properties Stock Just Drew Investor Attention EPR Properties (EPR) recently reported second quarter 2026 results, with higher sales and revenue compared with a year earlier, while net income and earnings per share declined and full year earnings guidance was maintained. See our latest analysis for EPR Properties. Despite the immediate share price reaction, with a 1 day share price return that declined 2.89%, EPR Properties has posted an 18.99% year to date share price return and a...

Why MYR Group Stock Is Back On Investor Radars MYR Group (MYRG) has drawn fresh attention after reporting second quarter 2026 results that showed higher sales, stronger earnings and a clear plan to use its balance sheet for growth and capital returns. See our latest analysis for MYR Group. Despite a softer patch in recent weeks, with the 30 day share price return down 21.23% and the 90 day share price return down 27.45%, MYR Group still has a year to date share price return of 45.69% and a 5...

Earnings event puts Watsco in focus for investors Watsco (WSO) is back on investor radar after its July 29 earnings report, which showed higher quarterly and half year sales alongside lower net income and diluted earnings per share compared with the prior year. See our latest analysis for Watsco. Since the earnings release on 29 July, Watsco's share price has remained under pressure, with a 30 day share price return down 14.9% and a 90 day share price return down 21.7%, while the 5 year total...

In early August 2026, Interface, Inc. reported past second-quarter results showing higher sales of US$395.7 million and stronger earnings, and modestly raised its full-year 2026 net sales guidance range to US$1.455 billion–US$1.485 billion while issuing new third-quarter sales guidance of US$370 million–US$380 million. The combination of improved profitability, tariff-refund benefits, and a higher full-year outlook suggests that Interface’s operational initiatives and order backlog are...

UBS recently upgraded Medtronic to Buy from Neutral after the company reported its strongest annual revenue growth in a decade, driven largely by its cardiac segment and new product launches, and outlined expectations for continued organic revenue expansion into fiscal 2027. This upgrade underscores how Medtronic’s momentum in high-growth cardiac ablation solutions and broader innovation efforts is reshaping perceptions of its turnaround progress. We’ll now explore how UBS’s upgrade,...

In recent weeks, Magnolia Oil & Gas completed a US$81.4 million share repurchase tranche, issued US$500.0 million of 6.625% senior notes due 2034 to help fund its pending WildFire acquisition, reported higher second‑quarter revenue and earnings alongside increased production, and raised its quarterly dividend to US$0.18 per share. Together, these actions highlight management’s emphasis on balance sheet-funded growth, ongoing capital returns, and an operating profile that has supported higher...

In July 2026, Axogen, Inc. reported second-quarter sales of US$69.73 million and a quarterly net loss of US$1.52 million, alongside higher year-to-date losses despite stronger revenue versus the prior year. At the same time, the company raised its full-year 2026 revenue outlook to at least US$279 million, highlighting management’s increased confidence in demand for its nerve repair portfolio despite current losses. With Axogen lifting its full-year revenue guidance, we’ll now examine how...

Q1 earnings and product update set the tone for MakeMyTrip MakeMyTrip (MMYT) is back in focus after Q1 FY 2027 results, the launch of its AI travel assistant Myra 2.0, and a confidential IPO filing for subsidiary MakeMyTrip India Limited. See our latest analysis for MakeMyTrip. At a share price of US$60.91, MakeMyTrip has seen a 35.45% 90 day share price return while its 1 year total shareholder return declined 35.57%, even though the 5 year total shareholder return is 130.20%. If Q1 results...

Life Time Group Holdings, Inc. recently reported past second-quarter 2026 results with higher sales of US$837.4 million, revenue of US$866.0 million, and net income of US$101.36 million, while also completing a US$73.37 million share repurchase under its February 2026 authorization. Alongside raising full-year 2026 revenue and net income guidance and outlining plans to open 14 mostly large-format new clubs, the company signaled a push to scale its premium fitness footprint with nearly double...

Why Royal Gold’s latest earnings and guidance matter for investors Royal Gold (RGLD) has drawn fresh attention after reporting second quarter 2026 results and issuing detailed sales guidance for the full year. The combination gives you more current information to assess the stock. For the second quarter ended June 30, 2026, the company reported sales of US$447.1 million compared with US$207.44 million a year earlier. Net income was US$236.39 million compared with US$132.35 million in the...

Kontoor Brands (KTB) has drawn fresh attention after its recent share price moves, with the stock roughly flat over the past day and down about 9% over the past month. See our latest analysis for Kontoor Brands. Looking beyond the recent pullback, Kontoor Brands has a 90 day share price return of 13.97% and a year to date share price return of 25.48%, while its 3 year total shareholder return of 73.38% and 5 year total shareholder return of 58.19% point to a stock where long term holders have...